Immuneering (IMRX)
(Delayed Data from NSDQ)
$1.86 USD
+0.02 (1.09%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $1.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.45 | 0.00% |
Earnings Summary
For their last quarter, Immuneering (IMRX) reported earnings of -$0.52 per share, missing the Zacks Consensus Estimate of -$0.48 per share. This reflects a negative earnings surprise of 8.33%. Look out for IMRX's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting a year-over-year increase of 11.76%.
Earnings History
Price & Consensus
Zacks News for IMRX
Wall Street Analysts Think Immuneering Corporation (IMRX) Could Surge 103.8%: Read This Before Placing a Bet
IMRX: What are Zacks experts saying now?
Zacks Private Portfolio Services